527
Views
51
CrossRef citations to date
0
Altmetric
Research Article

Novel films for drug delivery via the buccal mucosa using model soluble and insoluble drugs

, , &
Pages 1207-1220 | Received 25 Aug 2011, Accepted 22 Nov 2011, Published online: 29 Dec 2011

References

  • Mathias NR, Hussain MA. (2010). Non-invasive systemic drug delivery: Developability considerations for alternate routes of administration. J Pharm Sci, 99:1–20.
  • Shojaei AH. (1998). Buccal mucosa as a route for systemic drug delivery: A review. J Pharm Pharm Sci, 1:15–30.
  • Asane GS, Nirmal SA, Rasal KB, Naik AA, Mahadik MS, Rao YM. (2008). Polymers for mucoadhesive drug delivery system: A current status. Drug Dev Ind Pharm, 34:1246–1266.
  • Bruschi ML, de Freitas O. (2005). Oral bioadhesive drug delivery systems. Drug Dev Ind Pharm, 31:293–310.
  • Squier CA, Wertz PW. (1993). Permeability and the pathophysiology of oral mucosa. Adv Drug Delivery Rev, 12:13–24.
  • Sohi H, Ahuja A, Ahmad FJ, Khar RK. (2010). Critical evaluation of permeation enhancers for oral mucosal drug delivery. Drug Dev Ind Pharm, 36:254–282.
  • Yehia SA, El-Gazayerly ON, Basalious EB. (2008). Design and in vitro/in vivo evaluation of novel mucoadhesive buccal discs of an antifungal drug: Relationship between swelling, erosion, and drug release. AAPS PharmSciTech, 9:1207–1217.
  • Birudaraj R, Mahalingam R, Li X, Jasti BR. (2005). Advances in buccal drug delivery. Crit Rev Ther Drug Carrier Syst, 22:295–330.
  • Wang B, Siahaan T, Soltero R. (2005). Drug delivery: Principles and applications. Hoboken, New Jersey: Wiley-Interscience:35–42.
  • Smart JD. (2005). Buccal drug delivery. Expert Opin Drug Deliv, 2:507–517.
  • Degim T, Eglen B, Ocak O. (2006). A sustained release dosage form of acyclovir for buccal application: An experimental study in dogs. J Drug Target, 14:35–44.
  • Sasaki S, Koumi S, Sato R, Murata M, Nagasawa K, Sakurai E et al. (1998). Kinetics of buccal absorption of propafenone single oral loading dose in healthy humans. Gen Pharmacol, 31:589–591.
  • Boateng JS, Auffret AD, Matthews KH, Humphrey MJ, Stevens HN, Eccleston GM. (2010). Characterisation of freeze-dried wafers and solvent evaporated films as potential drug delivery systems to mucosal surfaces. Int J Pharm, 389:24–31.
  • Pather SI, Rathbone MJ, Senel S. (2008). Current status and the future of buccal drug delivery systems. Expert Opin Drug Deliv, 5:531–542.
  • Salamat-Miller N, Chittchang M, Johnston TP. (2005). The use of mucoadhesive polymers in buccal drug delivery. Adv Drug Deliv Rev, 57:1666–1691.
  • Yughuchi Y, Thuy TT, Urakawa H, Kajiwara K. (2002). Structural characteristics of carrageenan gels: Temperature and concentration dependence. Food Hydrocoll, 16:515–522.
  • Thommes M, Kleinebudde P. (2008). The behavior of different carrageenans in pelletization by extrusion/spheronization. Pharm Dev Technol, 13:27–35.
  • Rajput GC, Majmudar FD, Patel JK, Patel KN, Thakor RS, Patel BP, Rajgor NB. (2010). Stomach specific mucoadhesive tablets as controlled drug delivery system – A review work. Int J Pharm Bio Research, 1:30–41.
  • Kabanova AV, Batrakovaa EV, Alakhov VY. (2002). Pluronic® block copolymers as novel polymer therapeutics for drug and gene delivery. J Control Release, 82:189–212.
  • Dumortier G, Grossiord JL, Agnely F, Chaumeil JC. (2006). A review of poloxamer 407 pharmaceutical and pharmacological characteristics. Pharm Res, 23:2709–2728.
  • Craig DQM. (1995). A review of thermal methods used for the analysis of the crystal form, solution thermodynamics and glass-transition behaviour of polyethylene glycols. Thermochim Acta, 248:189–203.
  • Rosen MR. (2005). Delivery system handbook for personal care and cosmetic products: Technology, applications, and formulations. Norwich, UK: William Andrew Publishers, Inc. pp 120–124.
  • Boateng JS, Matthews KH, Stevens HN, Eccleston GM. (2008). Wound healing dressings and drug delivery systems: A review. J Pharm Sci, 97:2892–2923.
  • Gelcarinâ and Viscarinâ carrageenan, NF, Technical Bulletin online. Available at: www.avicel.com.
  • Alexandridis P, Hatton AT. (1995). Review: Poly (ethylene oxide)-poly (propylene oxide)-poly (ethylene oxide) block copolymer surfactants in aqueous solutions and at interfaces: Thermodynamics, structure, dynamics, and modelling. Colloids Surf A Physicochem Eng Asp, 96:1–46.
  • Hancock BC, Parks M. (2000). What is the true solubility advantage for amorphous pharmaceuticals? Pharm Res, 17:397–404.
  • Park K, Okano T, Ottenbrite M. (2010). Biomedical applications of hydrogels handbook. New York: Springer. pp 1–3.
  • Zelkó R, Orbán A, Süvegh K, Riedl Z, Rácz I. (2002). Effect of plasticizer on the dynamic surface tension and the free volume of Eudragit systems. Int J Pharm, 244:81–86.
  • Boateng JS, Stevens HN, Eccleston GM, Auffret AD, Humphrey MJ, Matthews KH. (2009). Development and mechanical characterization of solvent-cast polymeric films as potential drug delivery systems to mucosal surfaces. Drug Dev Ind Pharm, 35:986–996.
  • Slade L, Levine H. (2003). Water and the glass transition-dependence of the glass transition on composition and chemical structure: Special implications for flour functionality in cookie baking. J Food Process Eng, 22:143–188.
  • Di Martino P, Guyot-Hermann AM, Conflant P, Drache M, Guyot J. (1996). New pure paracetamol for direct compression: Orthorhombic form. Int J Pharm, 128:1–8.
  • Boldyreva V, Drebushchak V, Yulia P, Drebushchak T. (2004). DSC and adiabatic calorimetry study of the polymorphs of PM. J Therm Anal Calorim, 77:607–623.
  • Bley H, Fussnegger B, Bodmeier R. (2010). Characterization and stability of solid dispersions based on PEG/polymer blends. Int J Pharm, 390:165–173.
  • Matsumoto T, Zografi G. (1999). Physical properties of solid molecular dispersions of indomethacin with poly(vinylpyrrolidone) and poly(vinylpyrrolidone-co-vinyl-acetate) in relation to indomethacin crystallization. Pharm Res, 16:1722–1728.
  • Schmidta A, Wartewigb S, Picker K. (2003). Potential of carrageenans to protect drugs from polymorphic transformation. Eur J Pharm Biopharm, 56:101–110.
  • Mandal A.S, Chatterjee S, Karim K.M, Biswas N, Guha A, Behera M, Kuotsu K. (2011). Fabrication and in vitro evaluation of bidirectional release and stability studies of mucoadhesive donut-shaped captopril tablets. Drug Dev Ind Pharm, 1–12.
  • Siepmann J, Peppas NA. (2001). Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). Adv Drug Deliv Rev, 48:139–157.
  • Boateng JS, Matthews KH, Auffret AD, Humphrey MJ, Eccleston GM, Stevens HN. (2012). Comparison of the in vitro release characteristics of mucosal freeze-dried wafers and solvent-cast films containing an insoluble drug. Drug Dev Ind Pharm, 38:47–54.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.